Nozer M. Mehta,William Stern,Amy M. Sturmer,Morten Asser Karsdal,Kim Henriksen
申请号：
US13667578
公开号：
US09006172B2
申请日:
2012.11.02
申请国别(地区):
US
年份:
2015
代理人:
摘要：
A peptide having a sequence selected from SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17 and SEQ ID NO:18. Said peptide used for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or obesity, or of apetite suppression, or for mitigating insulin resistance, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test.
